{"id":"continuation-therapy","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL4298181","moleculeType":"Gene"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Continuation therapy is a treatment strategy rather than a specific drug, involving the sustained use of an established psychiatric agent (such as an antidepressant, antipsychotic, or mood stabilizer) following acute phase treatment. The goal is to consolidate therapeutic gains, maintain symptom remission, and reduce the risk of symptom recurrence or relapse in conditions like major depressive disorder, bipolar disorder, and schizophrenia.","oneSentence":"Continuation therapy refers to the ongoing administration of a psychiatric medication after an initial treatment phase to maintain clinical response and prevent relapse.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:30:55.189Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Maintenance treatment following acute phase response in major depressive disorder"},{"name":"Relapse prevention in bipolar disorder"},{"name":"Symptom maintenance in schizophrenia and other psychotic disorders"}]},"trialDetails":[{"nctId":"NCT05622136","phase":"PHASE2","title":"Dose-escalation of Regorafenib in Advanced Hepatocellular Carcinoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Instituto do Cancer do Estado de São Paulo","startDate":"2023-09-10","conditions":"Liver Cancer, Hepatocellular Carcinoma","enrollment":28},{"nctId":"NCT02443077","phase":"PHASE3","title":"Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2016-10-12","conditions":"Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type, Refractory Diffuse Large B-Cell Lymphoma Activated B-Cell Type","enrollment":94},{"nctId":"NCT05588141","phase":"PHASE1, PHASE2","title":"A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2023-05-16","conditions":"Brain Tumor, Cancer","enrollment":96},{"nctId":"NCT07494799","phase":"","title":"Efficacy of Different Interventions for Progressive Myopia After Orthokeratology Lens Wear","status":"NOT_YET_RECRUITING","sponsor":"Tianjin Medical University Eye Hospital","startDate":"2026-04-01","conditions":"Progressive Myopia, Pediatric Myopia, Orthokeratology-related Myopia Progression","enrollment":3890},{"nctId":"NCT02180867","phase":"PHASE2, PHASE3","title":"Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2014-07-11","conditions":"Alveolar Soft Part Sarcoma, Angiomatoid Fibrous Histiocytoma, Atypical Fibroxanthoma","enrollment":140},{"nctId":"NCT06290141","phase":"PHASE3","title":"A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)","status":"RECRUITING","sponsor":"Sanofi","startDate":"2024-08-21","conditions":"Chronic Inflammatory Demyelinating Polyneuropathy","enrollment":160},{"nctId":"NCT07496281","phase":"PHASE4","title":"OPTIA-AF Trial: Rhythm-Guided Antithrombotic Strategy After AF Ablation","status":"NOT_YET_RECRUITING","sponsor":"Ewha Womans University Mokdong Hospital","startDate":"2027-03-01","conditions":"Atrial Fibrillation (AF), Coronary Artery Disease, Drug-eluting Stent","enrollment":2},{"nctId":"NCT07195344","phase":"PHASE4","title":"Study Aiming to Compare the Plasma Exposure of the Payload (Free-DXd) in Patients Treated by T-DXd for Locally Advanced or Metastatic Breast Cancer According to Their BMI.","status":"RECRUITING","sponsor":"Institut Claudius Regaud","startDate":"2025-10-15","conditions":"Locally Advanced or Metastatic Breast Cancers","enrollment":210},{"nctId":"NCT05771480","phase":"PHASE3","title":"Durvalumab With Chemotherapy as First Line Treatment in Patients With Advanced Biliary Tract Cancers (aBTCs)","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2023-08-16","conditions":"Biliary Tract Cancer","enrollment":142},{"nctId":"NCT04185402","phase":"PHASE4","title":"Azithromycin Reduction to Reach Elimination of Trachoma","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2021-05-29","conditions":"Trachoma","enrollment":3931},{"nctId":"NCT07462663","phase":"","title":"SHAPE-ENDO: Multimodal Pre-Surgical Optimization in Patients With Obesity and Early-Stage Endometrial Cancer","status":"NOT_YET_RECRUITING","sponsor":"Hospital Universitari de Bellvitge","startDate":"2026-05","conditions":"Endometrial Cancer, Endometrial Cancer Stage I, Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I","enrollment":82},{"nctId":"NCT04637594","phase":"PHASE3","title":"Trying to Find the Correct Length of Treatment With Immune Checkpoint Therapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2022-05-27","conditions":"Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter Urothelial Carcinoma","enrollment":3},{"nctId":"NCT06882486","phase":"NA","title":"Post-immunotherapy Nephrectomy for Metastatic Kidney Cancer After Complete or Major Response to Systemic Therapy","status":"RECRUITING","sponsor":"Institut Paoli-Calmettes","startDate":"2026-05","conditions":"Kidney Cancer","enrollment":60},{"nctId":"NCT07286058","phase":"PHASE3","title":"Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis","status":"RECRUITING","sponsor":"Takeda","startDate":"2026-03-11","conditions":"Psoriatic Arthritis","enrollment":1182},{"nctId":"NCT05529927","phase":"PHASE2","title":"Efficacy and Safety of Sustained-release Dexamphetamine in Patients With Moderate to Severe Cocaine Use Disorder","status":"NOT_YET_RECRUITING","sponsor":"Parnassia Addiction Research Centre","startDate":"2026-05","conditions":"Cocaine Use Disorder","enrollment":204},{"nctId":"NCT04119544","phase":"NA","title":"Mirror Therapy Rehabilitation of the Upper Limb After Stroke (NEURO-MIROIR 2)","status":"RECRUITING","sponsor":"Clinique Les Trois Soleils","startDate":"2019-12-10","conditions":"Stroke","enrollment":66},{"nctId":"NCT05203172","phase":"PHASE4","title":"The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials","status":"RECRUITING","sponsor":"Pfizer","startDate":"2022-07-05","conditions":"Solid Tumors","enrollment":46},{"nctId":"NCT02129244","phase":"NA","title":"A Nurse Case Management Intervention to Improve MDR-TB/HIV Co-Infection Outcomes","status":"ACTIVE_NOT_RECRUITING","sponsor":"Johns Hopkins University","startDate":"2014-10","conditions":"MDR-TB, HIV","enrollment":3600},{"nctId":"NCT07276542","phase":"PHASE2, PHASE3","title":"Clinical Trial Exploring the Outpatient Treatment of Phantom Limb Pain With Ketamine Administration in a Six Month Study With a Minimum Remission Period of 7 Days Between Treatment Session. 25-30 Subjects With an Ongoing History of Significant PLP.--FDA and IRB Approved.","status":"RECRUITING","sponsor":"The Ketamine Research Foundation","startDate":"2026-01-15","conditions":"Phantom Limb Syndrome With Pain","enrollment":30},{"nctId":"NCT05081999","phase":"PHASE4","title":"De-Adoption of Beta-Blockers in Patients With Stable Ischemic Heart Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Alberta","startDate":"2023-01-30","conditions":"Stable Ischemic Heart Disease, Coronary Artery Disease, Beta-blocker Therapy","enrollment":59},{"nctId":"NCT01303094","phase":"PHASE2","title":"Continuing vs Intermittent Trabectedin in Patients With Advanced Soft Tissue Sarcoma","status":"COMPLETED","sponsor":"Centre Oscar Lambret","startDate":"2011-02","conditions":"Soft Tissue Sarcoma, Uterine Sarcoma","enrollment":53},{"nctId":"NCT05179876","phase":"PHASE3","title":"A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other Option","status":"RECRUITING","sponsor":"Actelion","startDate":"2022-05-04","conditions":"Hypertension, Pulmonary","enrollment":280},{"nctId":"NCT06289647","phase":"PHASE4","title":"Azithromycin Reduction to Reach Elimination of Trachoma B","status":"WITHDRAWN","sponsor":"University of California, San Francisco","startDate":"2024-10","conditions":"Trachoma","enrollment":""},{"nctId":"NCT07410039","phase":"PHASE4","title":"Therapy in the Acute Phase of NMOSD: A Multicenter Prospective Real-World Study","status":"RECRUITING","sponsor":"Chinese PLA General Hospital","startDate":"2026-02-01","conditions":"Neuromyelitis Optica Spectrum Disorder Attack","enrollment":200},{"nctId":"NCT07467252","phase":"PHASE2","title":"AIPH-TB: AI-Optimised Pyrazinamide-Hydroxychloroquine vs Standard RIPE for Drug-Sensitive Pulmonary Tuberculosis - A Phase II RCT","status":"NOT_YET_RECRUITING","sponsor":"Ministry of Health, Saudi Arabia","startDate":"2026-09","conditions":"Pulmonary Tuberculosis","enrollment":200},{"nctId":"NCT05672524","phase":"PHASE2","title":"A Study of Tucatinib and Trastuzumab in People With Rectal Cancer","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2022-12-30","conditions":"Adenocarcinoma of the Rectum, Locally Advanced Rectal Adenocarcinoma, Rectal Adenocarcinoma","enrollment":37},{"nctId":"NCT04880382","phase":"PHASE2","title":"Integrative Analysis of Tumor Microenvironment and Optimization of Immunotherapy Duration in NSCL Cancer Patients","status":"TERMINATED","sponsor":"Institut Bergonié","startDate":"2021-08-27","conditions":"Non Small Cell Lung Cancer","enrollment":8},{"nctId":"NCT06871228","phase":"NA","title":"Discontinuation of Anticoagulation With Intensive Rhythm Monitoring in Post-ablation Patients With Atrial Fibrillation","status":"RECRUITING","sponsor":"Beijing Anzhen Hospital","startDate":"2025-08-05","conditions":"Atrial Fibrillation (AF)","enrollment":4100},{"nctId":"NCT05866757","phase":"NA","title":"Discontinuation Study","status":"RECRUITING","sponsor":"University College Cork","startDate":"2023-08-28","conditions":"Multiple Myeloma, Cancer, Hematologic Cancer","enrollment":70},{"nctId":"NCT07444619","phase":"PHASE1","title":"A Phase I Study of Pazopanib in Combination With Trabectedin, Ipilimumab and Nivolumab (TraPIN) in Pediatric and Young Adult Patients With Recurrent Soft Tissue Sarcomas","status":"NOT_YET_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2026-08-31","conditions":"Soft Tissue Sarcomas","enrollment":18},{"nctId":"NCT07309796","phase":"NA","title":"Strengthening Exercises for Humeral Head Depressor Muscles","status":"RECRUITING","sponsor":"Hacettepe University","startDate":"2026-01-02","conditions":"Reverse Shoulder Arthroplasty, Depressor Muscle Training, Shoulder Rehabilitation","enrollment":27},{"nctId":"NCT04979728","phase":"","title":"HIV Outpatient Monitoring Evaluation Through Self-collection of Dried Blood Spots","status":"RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2021-05-27","conditions":"HIV Treatment, HIV Prevention","enrollment":150},{"nctId":"NCT07440160","phase":"NA","title":"Digitally Facilitated, Integrated Community and Facility-Based Interventions: The HEART-TB Trial Protocol","status":"ACTIVE_NOT_RECRUITING","sponsor":"Arba Minch University","startDate":"2025-07-01","conditions":"Tuberculosis","enrollment":278},{"nctId":"NCT06756256","phase":"NA","title":"Effect of Foot Insole on Body Alignment, and in Stroke Patients","status":"COMPLETED","sponsor":"University of Sharjah","startDate":"2025-03-20","conditions":"Stroke","enrollment":20},{"nctId":"NCT07298993","phase":"PHASE4","title":"Deprescribing Beta-Blockers in Elders With Heart Failure With Preserved Ejection Fraction (DEPRESCRIBE-HFpEF)","status":"ENROLLING_BY_INVITATION","sponsor":"Weill Medical College of Cornell University","startDate":"2026-02-02","conditions":"Heart Failure, HFpEF, HFpEF - Heart Failure With Preserved Ejection Fraction","enrollment":240},{"nctId":"NCT07053085","phase":"PHASE2","title":"A Study of Surgery and Radiotherapy in People With Breast Cancer","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2025-09-17","conditions":"Metastatic Breast Cancer, HER2-positive Breast Cancer","enrollment":162},{"nctId":"NCT03845712","phase":"PHASE2","title":"An Open-Label Study of Continuation Treatment With Combination Pyrimidine Nucleosides in Patients With TK2 Deficiency","status":"ACTIVE_NOT_RECRUITING","sponsor":"UCB BIOSCIENCES, Inc.","startDate":"2019-07-05","conditions":"Thymidine Kinase 2 Deficiency","enrollment":47},{"nctId":"NCT07434284","phase":"EARLY_PHASE1","title":"Exploratory Clinical Study of cCTL in Combination With Immunotherapy for Advanced Gynecologic Malignancies","status":"RECRUITING","sponsor":"Obstetrics & Gynecology Hospital of Fudan University","startDate":"2026-02","conditions":"Advanced Gynecological Cancers","enrollment":20},{"nctId":"NCT07335588","phase":"PHASE3","title":"A 52-Week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream in Adult Participants With Lichen Sclerosus","status":"NOT_YET_RECRUITING","sponsor":"LEO Pharma","startDate":"2026-05-06","conditions":"Lichen Sclerosus","enrollment":652},{"nctId":"NCT07423078","phase":"PHASE2","title":"Window of Opportunity in Preserving Laryngeal Function Trial","status":"NOT_YET_RECRUITING","sponsor":"Matthew Spector","startDate":"2026-03-31","conditions":"Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M), Locally Advanced Laryngeal Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma","enrollment":87},{"nctId":"NCT05785832","phase":"NA","title":"A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes","status":"COMPLETED","sponsor":"Tandem Diabetes Care, Inc.","startDate":"2023-06-01","conditions":"Type 2 Diabetes Treated With Insulin","enrollment":319},{"nctId":"NCT07420972","phase":"NA","title":"Pilot Study of Intrapartum Insulin Pump","status":"NOT_YET_RECRUITING","sponsor":"Medstar Health Research Institute","startDate":"2026-04","conditions":"Diabetes, Diabetes (Insulin-requiring, Type 1 or Type 2), Pregnancy","enrollment":30},{"nctId":"NCT06510972","phase":"NA","title":"Non-inferiority of Continuing Oral Intake Versus Fasting in Patients With Acute Respiratory Failure","status":"RECRUITING","sponsor":"University Hospital, Tours","startDate":"2025-02-05","conditions":"Respiratory Insufficiency, Fasting, Dysphagia","enrollment":754},{"nctId":"NCT07407231","phase":"NA","title":"Combined Chemotherapy And Ablative Radiotherapy (SBRT) As First-Line Treatment In Locally Advanced Inoperable Pancreatic Cancer (SBRT-PANC)","status":"RECRUITING","sponsor":"Institute of Oncology Ljubljana","startDate":"2021-09-01","conditions":"Locally Advanced Pancreatic Cancer","enrollment":18},{"nctId":"NCT05968430","phase":"PHASE3","title":"Open-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With Hypertension","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mineralys Therapeutics Inc.","startDate":"2023-07-14","conditions":"Hypertension","enrollment":1076},{"nctId":"NCT00400946","phase":"PHASE3","title":"05-001: Treatment of Acute Lymphoblastic Leukemia in Children","status":"COMPLETED","sponsor":"Dana-Farber Cancer Institute","startDate":"2005-04","conditions":"Drug/Agent Toxicity by Tissue/Organ, Leukemia","enrollment":800},{"nctId":"NCT07399301","phase":"NA","title":"High-Intensity Functional Training on Physical Performance and Mental Health in Elderly With Sarcopenia","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2026-03-01","conditions":"Geriatric Sarcopenia","enrollment":60},{"nctId":"NCT05684055","phase":"NA","title":"\"Community-based, eHealth Supported Management of Cardiovascular Risk Factors by Lay Village Health Workers (ComBaCaL aHT TwiC 1 & ComBaCaL aHT TwiC 2)","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2023-09-09","conditions":"Arterial Hypertension","enrollment":1354},{"nctId":"NCT07401901","phase":"NA","title":"Evaluation of the Safety and Effectiveness of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in Adults Living With Type 1 Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Medtronic Diabetes","startDate":"2026-07-15","conditions":"Type 1 Diabetes (T1D)","enrollment":230},{"nctId":"NCT06153069","phase":"PHASE4","title":"Asymptomatic TB With Innovative Modified Short-course Regimens","status":"RECRUITING","sponsor":"Huashan Hospital","startDate":"2025-11-21","conditions":"Tuberculosis","enrollment":426},{"nctId":"NCT06309238","phase":"NA","title":"Intensive Weight Loss Intervention Versus Bariatric Surgery for Adults With Severe and Complex Obesity: the LightBAR Randomised Trial","status":"RECRUITING","sponsor":"Carsten Dirksen","startDate":"2024-05-08","conditions":"Obesity","enrollment":500},{"nctId":"NCT06135714","phase":"PHASE3","title":"Metastasis-directed Therapy for Oligometastases of Breast Cancer","status":"RECRUITING","sponsor":"Tokyo Medical and Dental University","startDate":"2023-11-08","conditions":"Breast Cancer, Oligometastasis, Metastatic Breast Cancer","enrollment":340},{"nctId":"NCT04226547","phase":"NA","title":"Amplatzer Amulet LAAO vs. NOAC","status":"ACTIVE_NOT_RECRUITING","sponsor":"Abbott Medical Devices","startDate":"2020-07-07","conditions":"Atrial Fibrillation, Stroke, Bleeding","enrollment":2650},{"nctId":"NCT05415215","phase":"PHASE3","title":"A Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast Cancer","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2022-07-05","conditions":"Early Breast Cancer, Locally Advanced Breast Cancer, Inflammatory Breast Cancer","enrollment":346},{"nctId":"NCT03393975","phase":"PHASE3","title":"A Study of BAX 930 in Children, Teenagers, and Adults Born With Thrombotic Thrombocytopenic Purpura (TTP)","status":"COMPLETED","sponsor":"Baxalta now part of Shire","startDate":"2017-10-13","conditions":"Thrombotic Thrombocytopenic Purpura (TTP)","enrollment":52},{"nctId":"NCT07398001","phase":"NA","title":"Discontinuation of Antiplatelet Therapy After Drug-Coated Balloon Treatment","status":"NOT_YET_RECRUITING","sponsor":"Ulsan University Hospital","startDate":"2026-02-12","conditions":"Percutaneous Coronary Intervention, Antiplatelet Therapy, Drug-coated Balloon","enrollment":1042},{"nctId":"NCT07389265","phase":"PHASE3","title":"Continuation of Cetuximab Beyond First-Line Progression in Metastatic Colorectal Cancer","status":"RECRUITING","sponsor":"University of Campania Luigi Vanvitelli","startDate":"2025-10-01","conditions":"Metastatic Colorectal Cancer (mCRC)","enrollment":480},{"nctId":"NCT07389668","phase":"NA","title":"The Effect of the Use of Hand Massage Stimulation Techniques on the Hyperemesis Gravidarum","status":"COMPLETED","sponsor":"Inonu University","startDate":"2024-10-15","conditions":"Pregnancy Related","enrollment":70},{"nctId":"NCT01574274","phase":"PHASE2","title":"SC-PEG Asparaginase vs. Oncaspar in Pediatric Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Dana-Farber Cancer Institute","startDate":"2012-06","conditions":"Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma","enrollment":240},{"nctId":"NCT07389707","phase":"NA","title":"The Effect of Using Hand Massage Stimulation Techniques on Pain and Comfort in Pregnant Women Experiencing Lumbar Pain","status":"COMPLETED","sponsor":"Inonu University","startDate":"2024-10-15","conditions":"Pregnancy Related","enrollment":74},{"nctId":"NCT03863548","phase":"","title":"French Observational Study of Complications Associated With Anticoagulants and Antiplatelet Treatment in Retina/Vitreous Surgery","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2019-01-08","conditions":"Patients Undergoing Retina/Vitreous Surgery","enrollment":748},{"nctId":"NCT07387874","phase":"","title":"A Real-World Study of Trastuzumab Rezetecan in HER2+ Solid Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"Lixiaoling","startDate":"2025-07-10","conditions":"Recurrent or Metastatic Solid Tumors","enrollment":30},{"nctId":"NCT06948318","phase":"PHASE3","title":"A Continuation Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia","status":"RECRUITING","sponsor":"Takeda","startDate":"2025-08-14","conditions":"Immune Thrombocytopenic Purpura (ITP)","enrollment":150},{"nctId":"NCT05062889","phase":"PHASE2","title":"Exploiting Circulating Tumour DNA to Intensify the Postoperative Treatment Resected Colon Cancer Patients","status":"SUSPENDED","sponsor":"Gruppo Oncologico del Nord-Ovest","startDate":"2023-05-17","conditions":"Stage II Colon Cancer, Stage III Colon Cancer, HER2-positive Colon Cancer","enrollment":477},{"nctId":"NCT04774419","phase":"PHASE2","title":"Radiation and TSR-042 (Dostarlimab) in People With Endometrial Cancer After They Receive Surgery","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2021-04-02","conditions":"Endometrial Cancer","enrollment":62},{"nctId":"NCT05429320","phase":"PHASE2","title":"A Study of Local Ablative Therapy (LAT) in People With Non-Small Cell Lung Cancer (NSCLC)","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2022-06-15","conditions":"Non-small Cell Lung Cancer, Metastatic Non Small Cell Lung Cancer, Nsclc","enrollment":37},{"nctId":"NCT06925984","phase":"NA","title":"Stereotactic Radiotherapy for Oligoprogressive ER+/HER- Metastatic Breast Cancer, a Prospective Phase 2 Study (Oligopro-Breast)","status":"RECRUITING","sponsor":"Jules Bordet Institute","startDate":"2025-10-30","conditions":"OligoProgressive Metastatic Disease","enrollment":48},{"nctId":"NCT07367178","phase":"PHASE2","title":"Study of Sacituzumab Govitecan With Atropine to Improve Tolerability in Advanced TNBC and HR+/HER2- Breast Cancer","status":"NOT_YET_RECRUITING","sponsor":"MedSIR","startDate":"2026-07","conditions":"Breast Cancer, Advanced HR+/HER2- Breast Cancer, Advanced Triple-Negative Breast Cancer","enrollment":30},{"nctId":"NCT06486181","phase":"PHASE4","title":"Second Line Endovascular Treatment in Acute DVT","status":"NOT_YET_RECRUITING","sponsor":"Rush University Medical Center","startDate":"2026-04-01","conditions":"Deep Venous Thrombosis","enrollment":100},{"nctId":"NCT07360782","phase":"NA","title":"Personalized Pulsed Radiofrequency of the Greater Occipital Nerve for Medication Overuse Headache","status":"RECRUITING","sponsor":"Ankara City Hospital Bilkent","startDate":"2026-01-26","conditions":"Medication Overuse Headache","enrollment":90},{"nctId":"NCT07361692","phase":"NA","title":"Effectiveness of Transcranial Direct Current Stimulation (tDCS) in the Management of Complex Regional Pain Syndrome","status":"NOT_YET_RECRUITING","sponsor":"Polyclinique de l'Europe","startDate":"2026-03-01","conditions":"Complex Regional Pain Syndrome (CRPS)","enrollment":32},{"nctId":"NCT07303699","phase":"PHASE2","title":"ATORvastatin in Pulmonary TUBerculosis: a POPulation PharmacoKinetics -PharmacoDynamics Sub-study (ATORTUB popPK-PD)","status":"RECRUITING","sponsor":"Obafemi Awolowo University Teaching Hospital","startDate":"2026-01-03","conditions":"Pulmonary Tuberculosis (TB)","enrollment":80},{"nctId":"NCT05442216","phase":"PHASE2","title":"Tagraxofusp and Azacitidine With Venetoclax in Newly Diagnosed Secondary AML After Hypomethylating Agents","status":"RECRUITING","sponsor":"Joshua Zeidner","startDate":"2024-05-01","conditions":"Acute Myeloid Leukemia","enrollment":53},{"nctId":"NCT07363603","phase":"PHASE1, PHASE2","title":"Tianasen (ASO-GNAO1) for GNAO1-Encephalopathy With Epilepsy and Movement Disorders.","status":"RECRUITING","sponsor":"Pirogov Russian National Research Medical University","startDate":"2025-09-09","conditions":"GNAO1, Epilepsy, Hyperkinesis","enrollment":5},{"nctId":"NCT06788093","phase":"NA","title":"Reducing Overuse of Antibiotics With Decision Support","status":"RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2024-11-12","conditions":"Lower Respiratory Tract Infection, Pneumonia, Asthma","enrollment":2800},{"nctId":"NCT03020030","phase":"PHASE3","title":"Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents","status":"ACTIVE_NOT_RECRUITING","sponsor":"Dana-Farber Cancer Institute","startDate":"2017-03-03","conditions":"Acute Lymphoblastic Leukemia, Pediatric","enrollment":560},{"nctId":"NCT06885268","phase":"PHASE3","title":"Noradrenaline Versus Standard Blood Pressure Management for Perioperative Hypotension in Non-cardiac Surgery","status":"RECRUITING","sponsor":"Jagiellonian University","startDate":"2025-06-25","conditions":"Blood Pressure Management, Intraoperative Hypotension, Non-cardiac Surgery","enrollment":750},{"nctId":"NCT07339566","phase":"PHASE2, PHASE3","title":"Efficacy and Safety of Xeligekimab in the Treatment of Non-Radiographic Axial Spondyloarthritis","status":"NOT_YET_RECRUITING","sponsor":"Lingli Dong","startDate":"2026-01-31","conditions":"Nr-axial Spondyloarthritis, Non-Radiographical Axial Spondyloarthritis","enrollment":40},{"nctId":"NCT07094893","phase":"PHASE4","title":"Anti-EGFR Agents in Patients With Right-sided Advanced Colorectal Cancer With Wild-type RAS and AREG/EREG High Status","status":"NOT_YET_RECRUITING","sponsor":"Gruppo Oncologico del Nord-Ovest","startDate":"2026-04-15","conditions":"Colorectal Cancer","enrollment":280},{"nctId":"NCT07333066","phase":"PHASE3","title":"Phase III Randomized International Open Label Clinical Trial of Treatment Intensification With Docetaxel Plus Apalutamide in Patients With Metastatic Hormone-sensitive Prostate Cancer Who Did Not Achieve a Deep PSA Response After Initial Treatment With Apalutamide: REINFORCE Trial.","status":"NOT_YET_RECRUITING","sponsor":"Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD","startDate":"2026-03-31","conditions":"Metastatic Hormone-sensitive Prostate Cancer","enrollment":320},{"nctId":"NCT07333651","phase":"PHASE2","title":"125I Seed Implantation Plus Systemic Therapy for Oligoprogressive NSCLC or Colorectal Cancer","status":"NOT_YET_RECRUITING","sponsor":"Li Min","startDate":"2026-01","conditions":"Oligometastatic Disease","enrollment":90},{"nctId":"NCT03030261","phase":"PHASE2","title":"Elotuzumab, Pomalidomide, & Dexamethasone (Elo-Pom-Dex) With Second Autologous Stem Cell Transplantation for Relapsed Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2017-11-22","conditions":"Multiple Myeloma in Relapse","enrollment":25},{"nctId":"NCT07322146","phase":"PHASE4","title":"Trial of Reducing Inpatient Antibiotic Durations in Children","status":"NOT_YET_RECRUITING","sponsor":"University of California, San Francisco","startDate":"2026-02","conditions":"Pneumonia, Skin and Soft Tissue (SST) Infection, Urinary Tract Infections (UTIs)","enrollment":1200},{"nctId":"NCT07323706","phase":"NA","title":"Ayurvedic Diet in Myxedema","status":"RECRUITING","sponsor":"University of Copenhagen","startDate":"2024-10-01","conditions":"Hypothyroidism Primary","enrollment":88},{"nctId":"NCT06214910","phase":"NA","title":"ThiPhiSA: New Pathways to Prevention From Community TB Screening in South Africa","status":"COMPLETED","sponsor":"University of Washington","startDate":"2024-02-20","conditions":"Tuberculosis, HIV I Infection","enrollment":301},{"nctId":"NCT02756793","phase":"NA","title":"Stereotactic Radiotherapy for Oligo-Progressive Metastatic Cancer (The STOP Trial)","status":"ACTIVE_NOT_RECRUITING","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2016-10","conditions":"Metastatic Cancer","enrollment":90},{"nctId":"NCT07141264","phase":"PHASE2","title":"Adebrelimab Combine With Etoposide Capsules in ES-SCLC Maintenance Therapy","status":"RECRUITING","sponsor":"Tang-Du Hospital","startDate":"2025-08-25","conditions":"SCLC,Extensive Stage","enrollment":32},{"nctId":"NCT04769362","phase":"PHASE4","title":"Long-term Beta-blocker Therapy After Acute Myocardial Infarction","status":"RECRUITING","sponsor":"Samsung Medical Center","startDate":"2021-05-04","conditions":"Myocardial Infarction","enrollment":2540},{"nctId":"NCT06764615","phase":"PHASE2","title":"A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)","status":"RECRUITING","sponsor":"Takeda","startDate":"2025-05-28","conditions":"Crohn's Disease, Ulcerative Colitis","enrollment":183},{"nctId":"NCT07307443","phase":"PHASE2","title":"A Phase II Study of Anlotinib and Platinum-Based Chemotherapy in Patients With SMARCA4-Deficient, Locally Advanced or Metastatic Lung Cancer.","status":"NOT_YET_RECRUITING","sponsor":"Zhijie Wang","startDate":"2026-02-01","conditions":"SMARCA4-Deficient Tumor, Locally Advanced or Metastatic Lung Cancer","enrollment":28},{"nctId":"NCT03042169","phase":"PHASE3","title":"Surgical Resection Plus Chemotherapy Versus Chemotherapy Alone in Oligometastatic Stage IV Gastric Cancer","status":"TERMINATED","sponsor":"University Hospital, Lille","startDate":"2021-08-25","conditions":"Gastric Adenocarcinoma","enrollment":6},{"nctId":"NCT07295938","phase":"PHASE2","title":"TCM as an Adjuvant Treatment in Mycobacterium Abscessus Pulmonary Disease","status":"RECRUITING","sponsor":"Shanghai University of Traditional Chinese Medicine","startDate":"2025-09-08","conditions":"Mycobacterium Abscessus Pulmonary Disease","enrollment":352},{"nctId":"NCT04738812","phase":"PHASE3","title":"Determination of Adequate Tuberculosis Regimen in Patients Hospitalized With HIV-associated Severe Immune Suppression","status":"COMPLETED","sponsor":"ANRS, Emerging Infectious Diseases","startDate":"2022-04-21","conditions":"Tuberculosis, HIV-1-infection, Immuno-Deficiency","enrollment":1330},{"nctId":"NCT06160791","phase":"PHASE2","title":"Ruxolitinib With De-Intensified HLH-94 for the Treatment of Hemophagocytic Lymphohistiocytosis (HLH)","status":"RECRUITING","sponsor":"Jerry Lee, MD, MSc, MPhil","startDate":"2024-10-01","conditions":"Hemophagocytic Lymphohistiocytoses","enrollment":36},{"nctId":"NCT07292519","phase":"PHASE2","title":"Tirzepatide Combined With Cognitive-Behavioural Therapy (CBT) for Adults With Alcohol Use Disorder (AUD) and Overweight/Obesity (OOB)","status":"NOT_YET_RECRUITING","sponsor":"South West Sydney Local Health District","startDate":"2026-01-15","conditions":"Alcohol Use Disorder (AUD), Overweight or Obese, Comorbidities and Coexisting Conditions","enrollment":46},{"nctId":"NCT06472336","phase":"NA","title":"IntraCranial Atherosclerosis Related Large-vessel Occlusion Treated With Urgent Stenting (ICARUS)","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2025-03-31","conditions":"Stroke, Stroke, Acute Ischemic, Intracranial Atherosclerosis","enrollment":498},{"nctId":"NCT05144997","phase":"PHASE4","title":"Lorlatinib Continuation Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pfizer","startDate":"2021-12-28","conditions":"Non-Small-Cell Lung Cancer, NSCLC","enrollment":76},{"nctId":"NCT02627716","phase":"NA","title":"Joint Crisis Plan Effectiveness in Preventing Relapses in Schizophrenia and Schizoaffective Disorder","status":"COMPLETED","sponsor":"University Hospital, Lille","startDate":"2014-12-05","conditions":"Schizophrenia","enrollment":124},{"nctId":"NCT06034821","phase":"PHASE4","title":"Comparative Effectiveness of ECT vs. KETAMINE Over the Lifespan","status":"ENROLLING_BY_INVITATION","sponsor":"Brigham and Women's Hospital","startDate":"2023-10-01","conditions":"Acute Suicidal Depression (ASD)","enrollment":1500},{"nctId":"NCT07051525","phase":"NA","title":"Early Versus Late Stopping of Antibiotics in Adults With High-risk Hematological Malignancies/Receiving Cellular Therapies and Fever","status":"RECRUITING","sponsor":"Peter MacCallum Cancer Centre, Australia","startDate":"2025-12-03","conditions":"Leukemia, CART Therapy, Transplantation, Stem Cell","enrollment":214}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":308,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Continuation therapy","genericName":"Continuation therapy","companyName":"National Institute of Mental Health (NIMH)","companyId":"national-institute-of-mental-health-nimh","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Continuation therapy refers to the ongoing administration of a psychiatric medication after an initial treatment phase to maintain clinical response and prevent relapse. Used for Maintenance treatment following acute phase response in major depressive disorder, Relapse prevention in bipolar disorder, Symptom maintenance in schizophrenia and other psychotic disorders.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}